Timothy Eugene Sullivan
CIK 1707000 · Chief Financial Officer · last filed 2026-05-14
Timothy Eugene Sullivan is a Chief Financial Officer who has filed 41 SEC Form 4 insider transactions across 1 company since 2018. The most recent filing, for APLS, was dated May 14, 2026. Across all open-market trades the lifetime net is −$10.4M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
41
-$10.44M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) Delisted | Chief Financial Officer | 0 | $41.03 | $0 | -$10.44M | 41 | 2026-05-14 |
Recent Filings
41 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | −323,770 | $0 | EDGAR |
| 2026-04-20 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Gift (G) | — | $0 | EDGAR |
| 2026-01-30 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +58,140 | $0 | EDGAR |
| 2026-01-23 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −10,287 | -$223.9K | EDGAR |
| 2026-01-21 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −2,892 | -$57.2K | EDGAR |
| 2026-01-15 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −3,856 | -$85.6K | EDGAR |
| 2025-10-23 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | — | -$180.0K | EDGAR |
| 2025-09-10 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | −27,729 | -$1.04M | EDGAR |
| 2025-06-11 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-01-30 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −546 | -$16.1K | EDGAR |